Aqil Barina, Krishnan Bhuvaneswari, Curry Choladda V, Elghetany M Tarek, Szigeti Reka
Department of Pathology & Immunology, Baylor College of Medicine Houston, Texas, USA.
Int J Clin Exp Pathol. 2013 Nov 15;6(12):3009-13. eCollection 2013.
Post-transplantation lymphoproliferative disorder (PTLD) is an infrequent, but serious complication of solid organ and bone marrow transplantations. The vast majority of the cases are of B-cell origin and usually associated with Epstein-Barr virus (EBV) infection. The non-B (T and NK cell) PTLDs account for up to 14% of the PTLD cases in Western countries. We report a case of a 66-year-old man who received an orthotopic heart transplant for cardiomyopathy 7 years prior to presentation. He was referred to our institution with a hypermetabolic solitary right lower lobe lung nodule with an SUV of 9.2 on PET scan. The combined histomorphological and immunohistochemical pattern was most consistent with monomorphic PTLD, peripheral T-cell lymphoma with angioimmunoblastic features. Molecular studies showed clonal T-cell gamma receptor gene rearrangement. Primary pulmonary involvement of T-cell PTLD is extremely rare. This is the third reported case of T-cell PTLD after cardiac transplantation, primarily involving the lung. Further, studies will be required to determine the appropriate treatment and prognosis of this rare entity.
移植后淋巴细胞增生性疾病(PTLD)是实体器官和骨髓移植中一种不常见但严重的并发症。绝大多数病例起源于B细胞,通常与爱泼斯坦-巴尔病毒(EBV)感染有关。在西方国家,非B细胞(T细胞和NK细胞)PTLD占PTLD病例的比例高达14%。我们报告一例66岁男性病例,该患者在就诊前7年因心肌病接受了原位心脏移植。他因PET扫描显示右肺下叶有一个代谢活跃的孤立性肺结节,SUV为9.2而被转诊至我院。组织形态学和免疫组化联合检查结果最符合单形性PTLD,即具有血管免疫母细胞特征的外周T细胞淋巴瘤。分子研究显示克隆性T细胞γ受体基因重排。T细胞PTLD原发性肺受累极为罕见。这是心脏移植后第三例主要累及肺部的T细胞PTLD报告病例。此外,还需要进一步研究以确定这种罕见疾病的合适治疗方法和预后。